Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9013)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim SM, Park SH. Chemotherapy beyond second-line in advanced gastric cancer. World J Gastroenterol 2015; 21(29): 8811-8816 [PMID: 26269670 DOI: 10.3748/wjg.v21.i29.8811] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i29/8811.htm |
| Number | Citing Articles |
| 1 |
Ling Qiu, Hui Yang, Gaochao Lv, Ke Li, Guiqing Liu, Wei Wang, Shanshan Wang, Xueyu Zhao, Minhao Xie, Jianguo Lin. Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cells. European Journal of Pharmacology 2017; 810: 120 doi: 10.1016/j.ejphar.2017.06.035
|
| 2 |
Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang. Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review. Cancer Research and Treatment 2017; 49(4): 851 doi: 10.4143/crt.2016.176
|
| 3 |
Li Sun, Huijun Wang, Zhen Liu, Ying Meng, Meiqing Qiu, Yafei Ju, Shu Zhang. <p>Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival</p>. Cancer Management and Research 2020; : 10631 doi: 10.2147/CMAR.S275990
|
| 4 |
Wenwei Hu, Chen Wu, Xiaodong Li, Zhuojun Zheng, Quanqin Xie, Xu Deng, Jingting Jiang, Changping Wu. Serum IL-33 level is a predictor of progression-free survival after chemotherapy. Oncotarget 2017; 8(21): 35116 doi: 10.18632/oncotarget.16627
|
| 5 |
Hui Yang, Ling Qiu, Li Zhang, Gaochao Lv, Ke Li, Huixin Yu, Minhao Xie, Jianguo Lin. Platinum-zoledronate complex blocks gastric cancer cell proliferation by inducing cell cycle arrest and apoptosis. Tumor Biology 2016; 37(8): 10981 doi: 10.1007/s13277-016-4977-2
|
| 6 |
Rebecca C. Harvey. Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling Methods. Oncology and Therapy 2017; 5(1): 53 doi: 10.1007/s40487-017-0048-0
|
| 7 |
Young-Il Kim, Mi-Jung Kim, Sook Ryun Park, Hark Kyun Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Gwang Ha Kim, Moo In Park, Byung-Ho Nam, Young Iee Park, Il Ju Choi. Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Gastric Cancer 2017; 17(2): 120 doi: 10.5230/jgc.2017.17.e15
|
| 8 |
Xi Chen, Xuanxuan Dai, Peng Zou, Weiqian Chen, Vinothkumar Rajamanickam, Chen Feng, Weishan Zhuge, Chenyu Qiu, Qingqing Ye, Xiaohua Zhang, Guang Liang. Curcuminoid EF24 enhances the anti‐tumour activity of Akt inhibitor MK‐2206 through ROS‐mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. British Journal of Pharmacology 2017; 174(10): 1131 doi: 10.1111/bph.13765
|
| 9 |
Xiuying Ma, Jia Sun, Weijian Ye, Yewei Huang, Congcong Sun, Youli Tao, Tao Wang, Weitao Cong, Funeng Geng. Pro‑apoptotic effects of Kangfuxin on human stomach cancer cells and its underlying mechanism. Oncology Letters 2018; doi: 10.3892/ol.2018.8713
|
| 10 |
Jeeyun Lee, Razvan Cristescu, Kyoung-Mee Kim, Kyung Kim, Seung Tae Kim, Se Hoon Park, Won Ki Kang. Development of mesenchymal subtype gene signature for clinical application in gastric cancer. Oncotarget 2017; 8(39): 66305 doi: 10.18632/oncotarget.19985
|
| 11 |
Markus Moehler, Min-Hee Ryu, Mikhail Dvorkin, Keun-Wook Lee, Hasan Ş Coşkun, Rachel Wong, Hyun C Chung, Artem Poltoratsky, Akihito Tsuji, Chia Jui Yen, Alina S Muntean, Samuel Le Sourd, Gina M Vaccaro, Lindsay Overton, Narikazu Boku, Zev A Wainberg, Manish Patel, Maitreyi Sharma, Huiling Xiong, Ilaria Conti, Julien Taieb, Yung-Jue Bang. Maintenance Avelumab Versus Continuation of First-Line Chemotherapy in Gastric Cancer: JAVELIN Gastric 100 Study Design. Future Oncology 2019; 15(6): 567 doi: 10.2217/fon-2018-0668
|
| 12 |
KAIXIONG TAO, YUPING YIN, QIAN SHEN, YING CHEN, RUIDONG LI, WEILONG CHANG, JIE BAI, WEIZHEN LIU, LIANG SHI, PENG ZHANG. Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells. Biomedical Reports 2016; 4(3): 365 doi: 10.3892/br.2016.594
|
| 13 |
Lucrezia Ferrario, Federica Asperti, Giuseppe Aprile, Jacopo Giuliani. HTA and Gastric Cancer: Evaluating Alternatives in Third- and Fourth-Line Patients. International Journal of Environmental Research and Public Health 2023; 20(3): 2107 doi: 10.3390/ijerph20032107
|
| 14 |
Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone, Mario Scartozzi, Eufemia Stefania Lutrino, Davide Melisi, Lorenzo Antonuzzo, Antonio Pellegrino, Laura Ferrari, Roberto Bordonaro, Caterina Vivaldi, Lorenzo Gerratana, Silvia Bozzarelli, Roberto Filippi, Domenico Bilancia, Marco Russano, Giuseppe Aprile. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy. The Oncologist 2017; 22(12): 1463 doi: 10.1634/theoncologist.2017-0158
|
| 15 |
Hengxuan Ding, Junfeng Sun, Ruixin Li, Guojun Wang. Retracted Article: Long non-coding RNA GACAT1 alleviates doxorubicin and vincristine resistance through a PTEN/AKT/mTOR/S6K1 regulatory pathway in gastric cancer. RSC Advances 2019; 9(14): 8048 doi: 10.1039/C8RA10030F
|